X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1611) 1611
Publication (100) 100
Book Review (24) 24
Book Chapter (5) 5
Conference Proceeding (4) 4
Newsletter (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1206) 1206
male (761) 761
iloprost (742) 742
female (664) 664
iloprost - therapeutic use (605) 605
index medicus (500) 500
hypertension, pulmonary - drug therapy (473) 473
middle aged (471) 471
vasodilator agents - therapeutic use (459) 459
adult (430) 430
pulmonary hypertension (357) 357
animals (337) 337
prostacyclin (318) 318
treatment outcome (289) 289
aged (281) 281
inhaled iloprost (278) 278
epoprostenol - therapeutic use (269) 269
iloprost - administration & dosage (249) 249
hypertension, pulmonary - physiopathology (235) 235
respiratory system (234) 234
therapy (234) 234
cardiac & cardiovascular systems (230) 230
antihypertensive agents - therapeutic use (203) 203
pharmacology & pharmacy (203) 203
double-blind (191) 191
iloprost - pharmacology (182) 182
sildenafil (182) 182
vasodilator agents - administration & dosage (181) 181
administration, inhalation (174) 174
hypertension (172) 172
pulmonary arterial hypertension (171) 171
bosentan (169) 169
drug therapy, combination (169) 169
rats (156) 156
epoprostenol - analogs & derivatives (153) 153
drug therapy (138) 138
infusions, intravenous (138) 138
surgery (136) 136
platelet aggregation inhibitors - therapeutic use (135) 135
sildenafil citrate (133) 133
arterial-hypertension (132) 132
medicine, general & internal (131) 131
survival (131) 131
prostacyclin analog (129) 129
care and treatment (124) 124
time factors (123) 123
epoprostenol (122) 122
disease (115) 115
hypertension, pulmonary - etiology (115) 115
epoprostenol - administration & dosage (114) 114
rheumatology (109) 109
sulfonamides - therapeutic use (108) 108
continuous intravenous epoprostenol (106) 106
peripheral vascular disease (106) 106
nitric-oxide (104) 104
endothelin receptor antagonists (102) 102
piperazines - therapeutic use (101) 101
oral sildenafil (98) 98
treprostinil (98) 98
medicine & public health (93) 93
hemodynamics - drug effects (92) 92
epoprostenol - pharmacology (91) 91
vasodilator agents - pharmacology (91) 91
dose-response relationship, drug (90) 90
hypertension, pulmonary - diagnosis (88) 88
antihypertensive agents - administration & dosage (87) 87
ischemia - drug therapy (87) 87
placebo-controlled trial (87) 87
scleroderma (87) 87
inhaled nitric-oxide (86) 86
prospective studies (84) 84
scleroderma, systemic - complications (83) 83
ischemia (82) 82
adolescent (81) 81
blood pressure - drug effects (80) 80
retrospective studies (80) 80
research (77) 77
nitric oxide (76) 76
scleroderma, systemic - drug therapy (76) 76
pulmonary arteries (75) 75
risk factors (75) 75
infusion (74) 74
prognosis (72) 72
raynaud disease - drug therapy (72) 72
abridged index medicus (71) 71
child (70) 70
health aspects (70) 70
iloprost - adverse effects (70) 70
vascular resistance - drug effects (70) 70
double-blind method (69) 69
follow-up studies (69) 69
long-term treatment (69) 69
aerosolized iloprost (68) 68
prostaglandins - therapeutic use (68) 68
transplantation (68) 68
hemodynamics (67) 67
systemic sclerosis (67) 67
calcium channel blockers - therapeutic use (65) 65
critical care medicine (65) 65
calcium-channel blockers (64) 64
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1448) 1448
German (61) 61
French (38) 38
Italian (21) 21
Spanish (20) 20
Chinese (8) 8
Russian (8) 8
Turkish (5) 5
Polish (3) 3
Korean (2) 2
Norwegian (2) 2
Dutch (1) 1
Hungarian (1) 1
Japanese (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 8, pp. 1049 - 1066
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 11/2017, Volume 56, Issue 11, pp. 1865 - 1873
Journal Article
Journal Article
16.